These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6127542)

  • 1. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Lancet; 1982 Nov; 2(8307):1059-61. PubMed ID: 6127542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of five potassium chloride preparations on the upper gastrointestinal mucosa in healthy subjects receiving glycopyrrolate.
    Alsop WR; Moore JG; Rollins DE; Tolman KG
    J Clin Pharmacol; 1984; 24(5-6):235-9. PubMed ID: 6747020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of potassium chloride supplements on upper gastrointestinal mucosa.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Clin Pharmacol Ther; 1984 Jun; 35(6):852-5. PubMed ID: 6734038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral potassium supplements on upper gastrointestinal mucosa: multicenter clinical comparison of three formulations and placebo.
    Sinar DR; Bozymski EM; Blackshear JL
    Clin Ther; 1986; 8(2):157-63. PubMed ID: 3698061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic evaluation of slow-release potassium chloride preparations.
    Kendall C; Krantz KD; Berger A; Sharp T
    Clin Pharmacol Ther; 1985 Jul; 38(1):28-30. PubMed ID: 3891194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oral potassium chloride on upper gastrointestinal mucosa in healthy subjects: healing of lesions despite continuing treatment.
    Moore JG; Alsop WR; Freston JW; Tolman KG
    Gastrointest Endosc; 1986 Jun; 32(3):210-2. PubMed ID: 3522347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal lesions and potassium chloride supplements.
    Lancet; 1985 Mar; 1(8428):581-2. PubMed ID: 2857932
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal lesions and potassium chloride supplements.
    Leijonmarck CE; Räf L
    Lancet; 1985 Jan; 1(8419):56-7. PubMed ID: 2856988
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of wax matrix and microencapsulated potassium chloride in relation to upper gastrointestinal illness requiring hospitalization.
    Jick H; Jick SS; Walker AM; Stergachis A
    Pharmacotherapy; 1989; 9(4):204-6. PubMed ID: 2771805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper gastrointestinal tract bleeding from oral potassium chloride. Comparative risk from microencapsulated vs wax-matrix formulations.
    Strom BL; Carson JL; Schinnar R; Sim E; Maislin G; Soper K; Morse ML
    Arch Intern Med; 1987 May; 147(5):954-7. PubMed ID: 3495244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic comparison of solid and liquid potassium chloride supplements.
    Patterson DJ; Weinstein GS; Jeffries GH
    Lancet; 1983 Nov; 2(8358):1077-8. PubMed ID: 6138615
    [No Abstract]   [Full Text] [Related]  

  • 12. Micro-K potassium supplement.
    Med Lett Drugs Ther; 1982 Aug; 24(615):71-2. PubMed ID: 7099109
    [No Abstract]   [Full Text] [Related]  

  • 13. Irritative properties of two clinical potassium chloride formulations on duodenal mucosa of the cat and esophageal mucosa of the opossum.
    Alphin RS; O'Dell SW; Sancilio LF; Ward JW
    Dig Dis Sci; 1984 Jun; 29(6):508-12. PubMed ID: 6723482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal irritant potential of a potassium-sparing diuretic and of wax-matrix potassium chloride.
    Ryan JR; McMahon FG; Akdamar K; Ertan A; Agrawal N
    Clin Pharmacol Ther; 1984 Jan; 35(1):90-3. PubMed ID: 6690174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
    Festen HP
    Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid and solid potassium chloride: bioavailability and safety.
    Skoutakis VA; Acchiardo SR; Wojciechowski NJ; Carter CA
    Pharmacotherapy; 1984; 4(6):392-7. PubMed ID: 6514589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastrointestinal bleeding and ulcerogenic drugs].
    Téri N; Rácz I; Varga L
    Orv Hetil; 1983 Sep; 124(39):2363-5. PubMed ID: 6606151
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
    Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B
    Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on upper gastrointestinal mucosa of three delivery systems of potassium as supplement to frusemide administration.
    McLoughlin JC
    J R Soc Med; 1985 Jun; 78(6):459-62. PubMed ID: 3999081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroscopic localization of a microencapsulated KCl preparation in the human stomach.
    Graham DY; Smith JL; Jones RD; Rakhit A; Tipnis V; Hurley ME
    Gastrointest Endosc; 1987 Jun; 33(3):220-3. PubMed ID: 3297914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.